Endothelin-1 Stimulates Cytosolic Phospholipase A2 in Chinese Hamster Ovary Cells Stably Expressing the Human ETA or ETB Receptor Subtype

1994 ◽  
Vol 199 (2) ◽  
pp. 992-997 ◽  
Author(s):  
H. Schramek ◽  
Y. Wang ◽  
M. Konieczkowski ◽  
P.M. Rose ◽  
J.R. Sedor ◽  
...  
Keyword(s):  
Phospholipase A2 ◽  
Chinese Hamster Ovary ◽  
Chinese Hamster Ovary Cells ◽  
Chinese Hamster ◽  
Cytosolic Phospholipase A2 ◽  
Receptor Subtype ◽  
Ovary Cells ◽  
Endothelin 1 ◽  
Cytosolic Phospholipase ◽  
Etb Receptor

scholarly journals Activation of Phospholipase A2 by the Nociceptin Receptor Expressed in Chinese Hamster Ovary Cells

2002 ◽  
Vol 71 (5) ◽  
pp. 2186-2192 ◽  
Author(s):  
Kazuhiko Fukuda ◽  
Takehiro Shoda ◽  
Hitoshi Morikawa ◽  
Shigehisa Kato ◽  
Hiroyuki Mima ◽  
...  
Keyword(s):  
Phospholipase A2 ◽  
Chinese Hamster Ovary ◽  
Chinese Hamster Ovary Cells ◽  
Chinese Hamster ◽  
Ovary Cells ◽  
Nociceptin Receptor

Malignancy-related characteristics of wild type and drug-resistant chinese hamster ovary cells

Pathology ◽  
1993 ◽  
Vol 25 (3) ◽  
pp. 268-276 ◽  
Author(s):  
Wanda B. Mackinnon ◽  
Marlen Dyne ◽  
Rebecca Hancock ◽  
Carolyn E. Mountford ◽  
Adrienne J. Grant ◽  
...  
Keyword(s):  
Chinese Hamster Ovary ◽  
Chinese Hamster Ovary Cells ◽  
Chinese Hamster ◽  
Drug Resistant ◽  
Wild Type ◽  
Ovary Cells

Review of the current methods of Chinese Hamster Ovary (CHO) cells cultivation for production of therapeutic protein

2020 ◽  
Vol 17 ◽  
Author(s):  
Shazid Md. Sharker ◽  
Md. Atiqur Rahman
Keyword(s):  
Chinese Hamster Ovary ◽  
Cho Cells ◽  
Mass Production ◽  
Chinese Hamster Ovary Cells ◽  
Chinese Hamster ◽  
Therapeutic Protein ◽  
Specific Productivity ◽  
Ovary Cells ◽  
Further Development ◽  
Interesting Area

Most of clinical approved protein-based drugs or under in clinical trial have a profound impact in the treatment of critical diseases. The mammalian eukaryotic cells culture approaches, particularly the CHO (Chinese Hamster Ovary) cells are mainly used in the biopharmaceutical industry for the mass-production of therapeutic protein. Recent advances in CHO cell bioprocessing to yield recombinant proteins and monoclonal antibodies have enabled the expression of quality protein. The developments of cell lines are possible to upgrade specific productivity. As a result, it holds an interesting area for academic as well as industrial researchers around the world. This review will concentrate on the recent progress of the mammalian CHO cells culture technology and the future scope of further development for the mass-production of protein therapeutics.

Sign in / Sign up

Export Citation Format

Share Document